Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Evaluation of NSAID Use after Robotic Partial Nephrectomy

Trial Status: closed to accrual

This phase II trial tests how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in patients after robotic-assisted partial nephrectomy. To address the continued opioid problem in the United States, multiple institutions have successfully implemented minimal/no-opioid post-operative pain regimens after robotic surgery without worsening pain ratings or increased complications. These protocols rely on a combination of acetaminophen, non-steroidal anti-inflammatories (NSAIDs), and patient counseling. NSAIDs are cyclo-oxygenase (COX) inhibitors and are efficacious in reducing opioid use after surgery. Giving NSAIDs after robotic-assisted partial nephrectomy may work better at controlling pain without side effects.